HOWE & RUSLING INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
HOWE & RUSLING INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$8,000
-33.3%
563
-6.5%
0.00%0.0%
Q4 2019$12,000
+300.0%
6020.0%0.00%
+100.0%
Q3 2019$3,000
-25.0%
6020.0%0.00%0.0%
Q2 2019$4,0000.0%602
-4.9%
0.00%0.0%
Q1 2019$4,000
-20.0%
633
-5.0%
0.00%0.0%
Q4 2018$5,000
+66.7%
666
+72.1%
0.00%0.0%
Q3 2018$3,000
+50.0%
3870.0%0.00%
Q2 2018$2,0000.0%3870.0%0.00%
Q1 2018$2,0000.0%387
-14.8%
0.00%
Q4 2017$2,000
-33.3%
4540.0%0.00%
-100.0%
Q3 2017$3,0000.0%4540.0%0.00%0.0%
Q2 2017$3,000
+50.0%
454
+49.3%
0.00%
Q1 2017$2,0003040.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders